Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bright light augmentation in antidepressant nonresponders.

A J Levitt1, R T Joffe, S H Kennedy

  • 1Mood Disorders Clinic, Toronto General Hospital, Ontario, Canada.

The Journal of Clinical Psychiatry
|August 1, 1991
PubMed
Summary

Bright light therapy can significantly improve symptoms for individuals with treatment-resistant depression when added to standard antidepressant treatment. This approach offers a new option for those who haven't responded to other therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fetal cerebellar growth and Sylvian fissure maturation: international standards from Fetal Growth Longitudinal Study of INTERGROWTH-21<sup>st</sup> Project.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020
Same author

International standards for fetal brain structures based on serial ultrasound measurements from Fetal Growth Longitudinal Study of INTERGROWTH-21<sup>st</sup> Project.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020
Same author

Methodological approaches to situational analysis in global mental health: a scoping review.

Global mental health (Cambridge, England)·2019
Same author

Predictive accuracy of cerebroplacental ratio for adverse perinatal and neurodevelopmental outcomes in suspected fetal growth restriction: systematic review and meta-analysis.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2018
Same author

Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.

Neuroscience and biobehavioral reviews·2018
Same author

Genome-wide association studies of placebo and duloxetine response in major depressive disorder.

The pharmacogenomics journal·2017

Area of Science:

  • Psychiatry
  • Chronobiology
  • Pharmacology

Background:

  • Major depressive disorder (MDD) is a prevalent mood disorder.
  • Treatment resistance is a significant challenge in managing MDD.
  • Seasonal patterns in depression suggest a role for light exposure.

Purpose of the Study:

  • To investigate the efficacy of bright light therapy as an add-on treatment for depression.
  • To assess the benefits of light augmentation in patients with treatment-resistant depression.

Main Methods:

  • A cohort of ten patients with major depression were enrolled.
  • Participants had a history of antidepressant non-response or relapse.
  • A two-week course of bright light therapy was administered.

Related Experiment Videos

Main Results:

  • Seven out of ten patients experienced substantial symptom improvement.
  • Bright light augmentation demonstrated a positive impact on mood.

Conclusions:

  • Bright light therapy is a potential adjunctive treatment for depression.
  • This intervention may be beneficial for patients with treatment-resistant depression.
  • Light augmentation offers a novel therapeutic avenue for refractory mood disorders.